JP2015507004A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015507004A5 JP2015507004A5 JP2014557157A JP2014557157A JP2015507004A5 JP 2015507004 A5 JP2015507004 A5 JP 2015507004A5 JP 2014557157 A JP2014557157 A JP 2014557157A JP 2014557157 A JP2014557157 A JP 2014557157A JP 2015507004 A5 JP2015507004 A5 JP 2015507004A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- pyrazin
- trifluoromethyl
- amino
- methanone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XFTQRUTUGRCSGO-UHFFFAOYSA-N pyrazin-2-amine Chemical compound NC1=CN=CC=N1 XFTQRUTUGRCSGO-UHFFFAOYSA-N 0.000 claims 19
- -1 complexes Chemical class 0.000 claims 4
- 238000000034 method Methods 0.000 claims 3
- 238000006069 Suzuki reaction reaction Methods 0.000 claims 2
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 2
- 150000004677 hydrates Chemical class 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- IFSRLALWNRZNIR-UHFFFAOYSA-N (3-aminopyrrolidin-1-yl)-[4-[5-amino-6-[4-(trifluoromethyl)phenyl]pyrazin-2-yl]phenyl]methanone Chemical compound C1C(N)CCN1C(=O)C1=CC=C(C=2N=C(C(N)=NC=2)C=2C=CC(=CC=2)C(F)(F)F)C=C1 IFSRLALWNRZNIR-UHFFFAOYSA-N 0.000 claims 1
- ATFCGTCYACZEPJ-UHFFFAOYSA-N (3-aminopyrrolidin-1-yl)-[4-[5-amino-6-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-yl]phenyl]methanone Chemical compound C1C(N)CCN1C(=O)C1=CC=C(C=2N=C(C(N)=NC=2)C=2C=NC(=CC=2)C(F)(F)F)C=C1 ATFCGTCYACZEPJ-UHFFFAOYSA-N 0.000 claims 1
- ZCGDXSRKXDBFAA-UHFFFAOYSA-N (4-aminocyclohexyl)-[4-[5-amino-6-[4-(trifluoromethyl)phenyl]pyrazin-2-yl]phenyl]methanone Chemical compound C1CC(N)CCC1C(=O)C1=CC=C(C=2N=C(C(N)=NC=2)C=2C=CC(=CC=2)C(F)(F)F)C=C1 ZCGDXSRKXDBFAA-UHFFFAOYSA-N 0.000 claims 1
- UXRREWBCCJNKNA-UHFFFAOYSA-N (4-aminocyclohexyl)-[4-[5-amino-6-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-yl]phenyl]methanone Chemical compound C1CC(N)CCC1C(=O)C1=CC=C(C=2N=C(C(N)=NC=2)C=2C=NC(=CC=2)C(F)(F)F)C=C1 UXRREWBCCJNKNA-UHFFFAOYSA-N 0.000 claims 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 1
- MSGBHWXJZXCMDF-UHFFFAOYSA-N 3-(6-methoxypyridin-3-yl)-5-(4-methylsulfonylphenyl)pyrazin-2-amine Chemical compound C1=NC(OC)=CC=C1C1=NC(C=2C=CC(=CC=2)S(C)(=O)=O)=CN=C1N MSGBHWXJZXCMDF-UHFFFAOYSA-N 0.000 claims 1
- TVMWNJXWFMZIPH-UHFFFAOYSA-N 3-bromo-5-(4-methylsulfonylphenyl)pyrazin-2-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CN=C(N)C(Br)=N1 TVMWNJXWFMZIPH-UHFFFAOYSA-N 0.000 claims 1
- XNPURVXRWUXOPE-UHFFFAOYSA-N 4-[5-amino-6-[3-fluoro-4-(trifluoromethyl)phenyl]pyrazin-2-yl]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1C1=CN=C(N)C(C=2C=C(F)C(=CC=2)C(F)(F)F)=N1 XNPURVXRWUXOPE-UHFFFAOYSA-N 0.000 claims 1
- KFGMWGIKMVHIJZ-UHFFFAOYSA-N 4-[5-amino-6-[4-(methylcarbamoyl)phenyl]pyrazin-2-yl]benzamide Chemical compound C1=CC(C(=O)NC)=CC=C1C1=NC(C=2C=CC(=CC=2)C(N)=O)=CN=C1N KFGMWGIKMVHIJZ-UHFFFAOYSA-N 0.000 claims 1
- UBIZVPPIFUXEEB-UHFFFAOYSA-N 4-[5-amino-6-[4-(trifluoromethyl)phenyl]pyrazin-2-yl]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1C1=CN=C(N)C(C=2C=CC(=CC=2)C(F)(F)F)=N1 UBIZVPPIFUXEEB-UHFFFAOYSA-N 0.000 claims 1
- HARBDNRHGGVYDE-UHFFFAOYSA-N 4-[5-amino-6-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-yl]-n-methylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)NC)=CC=C1C1=CN=C(N)C(C=2C=NC(=CC=2)C(F)(F)F)=N1 HARBDNRHGGVYDE-UHFFFAOYSA-N 0.000 claims 1
- FRVNCQOSGYBWDN-UHFFFAOYSA-N 4-[5-amino-6-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-yl]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1C1=CN=C(N)C(C=2C=NC(=CC=2)C(F)(F)F)=N1 FRVNCQOSGYBWDN-UHFFFAOYSA-N 0.000 claims 1
- WNLGPWQMIXOKQG-UHFFFAOYSA-N 5-(4-cyclopropylsulfonylphenyl)-3-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-amine Chemical compound NC1=NC=C(C=2C=CC(=CC=2)S(=O)(=O)C2CC2)N=C1C1=CC=C(C(F)(F)F)N=C1 WNLGPWQMIXOKQG-UHFFFAOYSA-N 0.000 claims 1
- MOVWXDGLBZSEPD-UHFFFAOYSA-N 5-(4-ethylsulfonylphenyl)-3-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-amine Chemical compound C1=CC(S(=O)(=O)CC)=CC=C1C1=CN=C(N)C(C=2C=NC(=CC=2)C(F)(F)F)=N1 MOVWXDGLBZSEPD-UHFFFAOYSA-N 0.000 claims 1
- FRRKZFCMZMHXEM-UHFFFAOYSA-N 5-(4-methylsulfonylphenyl)-3-[4-(trifluoromethyl)phenyl]pyrazin-2-amine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CN=C(N)C(C=2C=CC(=CC=2)C(F)(F)F)=N1 FRRKZFCMZMHXEM-UHFFFAOYSA-N 0.000 claims 1
- UAEQPLLFQAIGHI-UHFFFAOYSA-N 5-(4-propan-2-ylsulfonylphenyl)-3-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-amine Chemical compound C1=CC(S(=O)(=O)C(C)C)=CC=C1C1=CN=C(N)C(C=2C=NC(=CC=2)C(F)(F)F)=N1 UAEQPLLFQAIGHI-UHFFFAOYSA-N 0.000 claims 1
- IKVDKCGDERAICR-UHFFFAOYSA-N 5-[4-(cyclopropylmethylsulfonyl)phenyl]-3-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-amine Chemical compound NC1=NC=C(C=2C=CC(=CC=2)S(=O)(=O)CC2CC2)N=C1C1=CC=C(C(F)(F)F)N=C1 IKVDKCGDERAICR-UHFFFAOYSA-N 0.000 claims 1
- QKMGZWDGSBJZNW-UHFFFAOYSA-N [4-[5-amino-6-[4-(trifluoromethyl)phenyl]pyrazin-2-yl]phenyl]-(1,4-diazepan-1-yl)methanone Chemical compound NC1=NC=C(C=2C=CC(=CC=2)C(=O)N2CCNCCC2)N=C1C1=CC=C(C(F)(F)F)C=C1 QKMGZWDGSBJZNW-UHFFFAOYSA-N 0.000 claims 1
- QRCMCFJPTPLCCR-UHFFFAOYSA-N [4-[5-amino-6-[4-(trifluoromethyl)phenyl]pyrazin-2-yl]phenyl]-(3-hydroxypyrrolidin-1-yl)methanone Chemical compound NC1=NC=C(C=2C=CC(=CC=2)C(=O)N2CC(O)CC2)N=C1C1=CC=C(C(F)(F)F)C=C1 QRCMCFJPTPLCCR-UHFFFAOYSA-N 0.000 claims 1
- FKDIWALLMXDOBS-UHFFFAOYSA-N [4-[5-amino-6-[4-(trifluoromethyl)phenyl]pyrazin-2-yl]phenyl]-(4-hydroxypiperidin-1-yl)methanone Chemical compound NC1=NC=C(C=2C=CC(=CC=2)C(=O)N2CCC(O)CC2)N=C1C1=CC=C(C(F)(F)F)C=C1 FKDIWALLMXDOBS-UHFFFAOYSA-N 0.000 claims 1
- JKGSEXNAJXBRDM-UHFFFAOYSA-N [4-[5-amino-6-[4-(trifluoromethyl)phenyl]pyrazin-2-yl]phenyl]-(4-methyl-1,4-diazepan-1-yl)methanone Chemical compound C1CN(C)CCCN1C(=O)C1=CC=C(C=2N=C(C(N)=NC=2)C=2C=CC(=CC=2)C(F)(F)F)C=C1 JKGSEXNAJXBRDM-UHFFFAOYSA-N 0.000 claims 1
- RMTRGLNLRIPBEP-UHFFFAOYSA-N [4-[5-amino-6-[4-(trifluoromethyl)phenyl]pyrazin-2-yl]phenyl]-(4-methylpiperazin-1-yl)methanone Chemical compound C1CN(C)CCN1C(=O)C1=CC=C(C=2N=C(C(N)=NC=2)C=2C=CC(=CC=2)C(F)(F)F)C=C1 RMTRGLNLRIPBEP-UHFFFAOYSA-N 0.000 claims 1
- MPJVEQUTYMMVFV-UHFFFAOYSA-N [4-[5-amino-6-[4-(trifluoromethyl)phenyl]pyrazin-2-yl]phenyl]-(4-tert-butylpiperazin-1-yl)methanone Chemical compound C1CN(C(C)(C)C)CCN1C(=O)C1=CC=C(C=2N=C(C(N)=NC=2)C=2C=CC(=CC=2)C(F)(F)F)C=C1 MPJVEQUTYMMVFV-UHFFFAOYSA-N 0.000 claims 1
- JTVQYNCQTWIEOM-UHFFFAOYSA-N [4-[5-amino-6-[4-(trifluoromethyl)phenyl]pyrazin-2-yl]phenyl]-morpholin-4-ylmethanone Chemical compound NC1=NC=C(C=2C=CC(=CC=2)C(=O)N2CCOCC2)N=C1C1=CC=C(C(F)(F)F)C=C1 JTVQYNCQTWIEOM-UHFFFAOYSA-N 0.000 claims 1
- GGOFGCMPKAWHEZ-UHFFFAOYSA-N [4-[5-amino-6-[4-(trifluoromethyl)phenyl]pyrazin-2-yl]phenyl]-piperazin-1-ylmethanone Chemical compound NC1=NC=C(C=2C=CC(=CC=2)C(=O)N2CCNCC2)N=C1C1=CC=C(C(F)(F)F)C=C1 GGOFGCMPKAWHEZ-UHFFFAOYSA-N 0.000 claims 1
- HMDDHIGAWLFZAP-UHFFFAOYSA-N [4-[5-amino-6-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-yl]phenyl]-(1,4-diazepan-1-yl)methanone Chemical compound NC1=NC=C(C=2C=CC(=CC=2)C(=O)N2CCNCCC2)N=C1C1=CC=C(C(F)(F)F)N=C1 HMDDHIGAWLFZAP-UHFFFAOYSA-N 0.000 claims 1
- SXLQIWVYFPJURZ-UHFFFAOYSA-N [4-[5-amino-6-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-yl]phenyl]-(3-hydroxypyrrolidin-1-yl)methanone Chemical compound NC1=NC=C(C=2C=CC(=CC=2)C(=O)N2CC(O)CC2)N=C1C1=CC=C(C(F)(F)F)N=C1 SXLQIWVYFPJURZ-UHFFFAOYSA-N 0.000 claims 1
- BFOZDYPVOAYCER-UHFFFAOYSA-N [4-[5-amino-6-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-yl]phenyl]-(4-hydroxypiperidin-1-yl)methanone Chemical compound NC1=NC=C(C=2C=CC(=CC=2)C(=O)N2CCC(O)CC2)N=C1C1=CC=C(C(F)(F)F)N=C1 BFOZDYPVOAYCER-UHFFFAOYSA-N 0.000 claims 1
- VGLYCNNNCNWXSU-UHFFFAOYSA-N [4-[5-amino-6-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-yl]phenyl]-(4-methyl-1,4-diazepan-1-yl)methanone Chemical compound C1CN(C)CCCN1C(=O)C1=CC=C(C=2N=C(C(N)=NC=2)C=2C=NC(=CC=2)C(F)(F)F)C=C1 VGLYCNNNCNWXSU-UHFFFAOYSA-N 0.000 claims 1
- GJQCXICOYCNNKH-UHFFFAOYSA-N [4-[5-amino-6-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-yl]phenyl]-(4-methylpiperazin-1-yl)methanone Chemical compound C1CN(C)CCN1C(=O)C1=CC=C(C=2N=C(C(N)=NC=2)C=2C=NC(=CC=2)C(F)(F)F)C=C1 GJQCXICOYCNNKH-UHFFFAOYSA-N 0.000 claims 1
- QYLBQFPRQVBPDZ-UHFFFAOYSA-N [4-[5-amino-6-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-yl]phenyl]-(4-tert-butylpiperazin-1-yl)methanone Chemical compound C1CN(C(C)(C)C)CCN1C(=O)C1=CC=C(C=2N=C(C(N)=NC=2)C=2C=NC(=CC=2)C(F)(F)F)C=C1 QYLBQFPRQVBPDZ-UHFFFAOYSA-N 0.000 claims 1
- OIZOYBBNHJPCGH-UHFFFAOYSA-N [4-[5-amino-6-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-yl]phenyl]-morpholin-4-ylmethanone Chemical compound NC1=NC=C(C=2C=CC(=CC=2)C(=O)N2CCOCC2)N=C1C1=CC=C(C(F)(F)F)N=C1 OIZOYBBNHJPCGH-UHFFFAOYSA-N 0.000 claims 1
- KTOXEDIFORKAKJ-UHFFFAOYSA-N [4-[5-amino-6-[6-(trifluoromethyl)pyridin-3-yl]pyrazin-2-yl]phenyl]-piperazin-1-ylmethanone Chemical compound NC1=NC=C(C=2C=CC(=CC=2)C(=O)N2CCNCC2)N=C1C1=CC=C(C(F)(F)F)N=C1 KTOXEDIFORKAKJ-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 239000003430 antimalarial agent Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 201000004792 malaria Diseases 0.000 claims 1
- WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 claims 1
- ZHDORMMHAKXTPT-UHFFFAOYSA-N n-benzoylbenzamide Chemical compound C=1C=CC=CC=1C(=O)NC(=O)C1=CC=CC=C1 ZHDORMMHAKXTPT-UHFFFAOYSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261600324P | 2012-02-17 | 2012-02-17 | |
| US61/600,324 | 2012-02-17 | ||
| PCT/IB2013/051235 WO2013121387A1 (en) | 2012-02-17 | 2013-02-15 | Anti -malarial agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015507004A JP2015507004A (ja) | 2015-03-05 |
| JP2015507004A5 true JP2015507004A5 (enExample) | 2016-02-12 |
| JP6226889B2 JP6226889B2 (ja) | 2017-11-08 |
Family
ID=48014134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014557157A Expired - Fee Related JP6226889B2 (ja) | 2012-02-17 | 2013-02-15 | 新規抗マラリア薬 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9266842B2 (enExample) |
| EP (1) | EP2814820B1 (enExample) |
| JP (1) | JP6226889B2 (enExample) |
| CN (1) | CN104136426B (enExample) |
| BR (1) | BR112014020212B1 (enExample) |
| CA (1) | CA2864483A1 (enExample) |
| CY (1) | CY1118074T1 (enExample) |
| DK (1) | DK2814820T3 (enExample) |
| ES (1) | ES2589283T3 (enExample) |
| HR (1) | HRP20161237T1 (enExample) |
| HU (1) | HUE029876T2 (enExample) |
| IN (1) | IN2014MN01622A (enExample) |
| LT (1) | LT2814820T (enExample) |
| ME (1) | ME02535B (enExample) |
| PL (1) | PL2814820T3 (enExample) |
| PT (1) | PT2814820T (enExample) |
| RS (1) | RS55201B1 (enExample) |
| SI (1) | SI2814820T1 (enExample) |
| SM (1) | SMT201600441B (enExample) |
| WO (1) | WO2013121387A1 (enExample) |
| ZA (1) | ZA201406786B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT2814820T (lt) * | 2012-02-17 | 2016-10-25 | University Of Cape Town | Antimaliariniai agentai |
| EP3118198A1 (en) | 2015-07-13 | 2017-01-18 | MMV Medicines for Malaria Venture | Anti-malarial agents |
| WO2017067881A1 (en) | 2015-10-19 | 2017-04-27 | Glaxosmithkline Intellectual Property Development Limited | Pyrazine compounds for use in the treatment of parasitic protozoal infections |
| ES2928240T3 (es) * | 2018-01-24 | 2022-11-16 | Glaxosmithkline Ip Dev Ltd | Compuestos novedosos para el tratamiento de infecciones parasitarias |
| CN112142715A (zh) * | 2020-10-10 | 2020-12-29 | 鲁南制药集团股份有限公司 | 一种2-氨基-5-杂环基取代的吡嗪衍生物及其用途 |
| US20250122167A1 (en) * | 2021-11-23 | 2025-04-17 | Glaxosmithkline Intellectual Property Development Limited | Pyrazine Compounds Useful in the Treatment of Parasitic Protozoal Infection |
| JP2025531008A (ja) | 2022-08-09 | 2025-09-19 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | フロピリミジン誘導体 |
| WO2024033280A1 (en) | 2022-08-09 | 2024-02-15 | Merck Patent Gmbh | Furopyridin and furopyrimidin, inhibitors of pi4k, for use in the treatment of parasite infection and malaria |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2545422C (en) * | 2003-12-03 | 2015-06-02 | Cytopia Research Pty Ltd | Tubulin inhibitors |
| US20080039450A1 (en) * | 2006-06-22 | 2008-02-14 | Jensen Annika J | Compounds |
| EP1900727A1 (en) * | 2006-08-30 | 2008-03-19 | Cellzome Ag | Aminopyridine derivatives as kinase inhibitors |
| GB0625659D0 (en) * | 2006-12-21 | 2007-01-31 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| JP5735986B2 (ja) * | 2010-01-18 | 2015-06-17 | エムエムヴィ メディシンズ フォア マラリア ヴェンチャーＭｍｖ Ｍｅｄｉｃｉｎｅｓ Ｆｏｒ Ｍａｌａｒｉａ Ｖｅｎｔｕｒｅ | 新規抗マラリア剤 |
| US9062008B2 (en) * | 2010-05-12 | 2015-06-23 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| CA2828578A1 (en) * | 2011-03-04 | 2012-09-13 | Lexicon Pharmaceuticals, Inc. | Mst1 kinase inhibitors and methods of their use |
| LT2814820T (lt) * | 2012-02-17 | 2016-10-25 | University Of Cape Town | Antimaliariniai agentai |
-
2013
- 2013-02-15 LT LTEP13712926.8T patent/LT2814820T/lt unknown
- 2013-02-15 EP EP13712926.8A patent/EP2814820B1/en active Active
- 2013-02-15 HU HUE13712926A patent/HUE029876T2/en unknown
- 2013-02-15 PT PT137129268T patent/PT2814820T/pt unknown
- 2013-02-15 SI SI201330290A patent/SI2814820T1/sl unknown
- 2013-02-15 CN CN201380009373.9A patent/CN104136426B/zh not_active Expired - Fee Related
- 2013-02-15 CA CA2864483A patent/CA2864483A1/en not_active Abandoned
- 2013-02-15 DK DK13712926.8T patent/DK2814820T3/en active
- 2013-02-15 PL PL13712926T patent/PL2814820T3/pl unknown
- 2013-02-15 WO PCT/IB2013/051235 patent/WO2013121387A1/en not_active Ceased
- 2013-02-15 ME MEP-2016-214A patent/ME02535B/me unknown
- 2013-02-15 ES ES13712926.8T patent/ES2589283T3/es active Active
- 2013-02-15 IN IN1622MUN2014 patent/IN2014MN01622A/en unknown
- 2013-02-15 BR BR112014020212-5A patent/BR112014020212B1/pt not_active IP Right Cessation
- 2013-02-15 RS RS20160814A patent/RS55201B1/sr unknown
- 2013-02-15 JP JP2014557157A patent/JP6226889B2/ja not_active Expired - Fee Related
- 2013-02-15 HR HRP20161237TT patent/HRP20161237T1/hr unknown
- 2013-02-15 US US14/379,332 patent/US9266842B2/en not_active Expired - Fee Related
-
2014
- 2014-09-16 ZA ZA2014/06786A patent/ZA201406786B/en unknown
-
2016
- 2016-10-10 CY CY20161100998T patent/CY1118074T1/el unknown
- 2016-12-02 SM SM201600441T patent/SMT201600441B/it unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015507004A5 (enExample) | ||
| JP5650735B2 (ja) | タンパク質キナーゼ調節剤としてのピリジンおよびピラジン誘導体 | |
| JP2019527718A5 (enExample) | ||
| KR101941929B1 (ko) | 2-아미노피리미딘계 화합물 및 이의 약물 조성물과 응용 | |
| JP2020033357A5 (enExample) | ||
| JP2020111602A (ja) | 抗がんおよび抗増殖活性を示すｎ−アシル−ｎ’−（ピリジン−２−イル）尿素および類似体 | |
| JP2017502940A5 (enExample) | ||
| JP2014521653A5 (enExample) | ||
| JP2015531773A (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| JP2015503529A5 (enExample) | ||
| JP2016513660A5 (enExample) | ||
| JP2014139226A5 (enExample) | ||
| JP2013517264A5 (enExample) | ||
| JP2017537948A5 (enExample) | ||
| ME02535B (me) | Antimalarijski agensi | |
| JP2010539110A5 (enExample) | ||
| JP2015529224A5 (enExample) | ||
| JP2013534245A5 (enExample) | ||
| JP2007504160A5 (enExample) | ||
| JP2019505595A5 (enExample) | ||
| JP2017536342A5 (enExample) | ||
| RU2018131775A (ru) | 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета | |
| JP2021500332A5 (enExample) | ||
| JP2017519818A5 (enExample) | ||
| JP2008509955A5 (enExample) |